| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Yan,Wen-Liang | Chairman | 9.74% | YONG FENG INVESTMENT DEVELOPMENT LTD. |
| Wu,Yong-Zhong | Director | 10.08% | DE HENG INVESTMENT LTD. |
| Chen,Chu-Wen | Director | 2.39% | |
| Fu,Tian-Cong | Director | 14.32% | RI BEN ADVANCED MATERIALS LTD. |
| Yan,Yong-Cheng | Director | 9.74% | YONG FENG INVESTMENT DEVELOPMENT LTD. |
| Zhang,Bing-Feng | Director | 10.08% | DE HENG INVESTMENT LTD. |
| Zhan,Hui-Jun | Independent Director | 0.00% | |
| Huang,Xiao-Xin | Independent Director | 0.00% | |
| Li,Qin-Cheng | Independent Director | 0.00% |
Change Capital to 1,000,000,000
2024/06/11
Change Company Name to LIANYOU METAL TECHNOLOGY CO., LTD. (FORMER NAME: LIANYOU METAL TECHNOLOGY CO., LTD.)
2023/09/28
Change Company Name to LIANYOU METALS CO., LTD.
2023/09/28
Change Company Name to LIANYOU METAL TECHNOLOGY CO., LTD. (FORMER NAME: LIANYOU METAL TECHNOLOGY CO., LTD.)
2023/09/01
Change Company Name to LIANYOU METALS CO., LTD.
2023/09/01
Change Company Name to LIANYOU METAL TECHNOLOGY CO., LTD. (FORMER NAME: LIANYOU METAL TECHNOLOGY CO., LTD.)
2023/07/10
Change Company Name to LIANYOU METALS CO., LTD.
2023/07/10
Change Company Name to LIANYOU METAL TECHNOLOGY CO., LTD. (FORMER NAME: LIANYOU METAL TECHNOLOGY CO., LTD.)
2023/01/06
Change Company Name to LIANYOU METALS CO., LTD.
2023/01/06
Change Company Name to LIANYOU METAL TECHNOLOGY CO., LTD. (FORMER NAME: LIANYOU METAL TECHNOLOGY CO., LTD.)
2022/07/11
Change Company Name to LIANYOU METALS CO., LTD.
2022/07/11
Change Capital to 500,000,000
2021/03/23
Change Company Name to LIANYOU METALS CO., LTD.
2020/09/24
Change Capital to 80,000,000
2019/04/18
Change Capital to 48,000,000
2018/09/17
Change Person in Charge to Yan,Wen-Liang
2018/06/01
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 171,601 | 645,326 | 916,373 |
| Operating cost | 175,092 | 557,346 | 834,553 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | -3,491 | 87,980 | 81,820 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | -3,491 | 87,980 | 81,820 |
| Operating expenses | 18,489 | 32,792 | 66,085 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -21,980 | 55,188 | 15,735 |
| Non-operating income and expenses | -3,132 | -919 | -14,335 |
| Net profit (loss) before tax | -25,112 | 54,269 | 1,400 |
| Income tax expense (benefits) | -6,782 | 9,348 | -2,607 |
| Net profit (loss) of ongoing business for the current period | -18,330 | 44,921 | 4,007 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -18,330 | 44,921 | 4,007 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -18,330 | 44,921 | 4,007 |
| Net profit (loss) attributable to owners of parent company | -18,330 | 44,921 | 4,007 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | -18,330 | 44,921 | 4,007 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 1 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -225,238 | 107,982 | -157,126 |
| Net cash inflows (outflows) from investing activities | -58,813 | -251,324 | -147,583 |
| Net cash inflow (outflow) from financing activities | 271,353 | 276,094 | 340,571 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -12,698 | 132,752 | 35,862 |
| Beginning balance of cash and cash equivalents | 84,746 | 48,143 | 12,281 |
| Ending balance of cash and cash equivalents | 72,048 | 180,895 | 48,143 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 946,755 | 908,385 | 747,086 |
| Non-current asset | 1,159,123 | 970,032 | 807,124 |
| Total asset | 2,105,878 | 1,878,417 | 1,554,210 |
| Current liability | 749,171 | 852,837 | 708,973 |
| Non-current liability | 580,166 | 246,472 | 108,262 |
| Total liability | 1,329,337 | 1,099,309 | 817,235 |
| share capital | 346,639 | 346,215 | 309,460 |
| Equity - secruity token | - | - | - |
| capital reserve | 369,860 | 367,747 | 398,688 |
| retained earning | 62,452 | 67,003 | 31,366 |
| Other equity | -2,410 | -1,857 | -2,539 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 776,541 | 779,108 | 736,975 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 776,541 | 779,108 | 736,975 |
| Share capital awaiting retirement (unit: share) | 0 | 32,500 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 22 | 25 | 23 |
